MTP 1403

structure given in first source

Also Known As:

2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano(3,2-d)pyrimidine; MTP-1403; 6H-Thiopyrano(3,2-d)pyrimidin-2-amine, 7,8-dihydro-4-(1-piperazinyl)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ketosis 04/01/1986 - "MTP-1403 caused a decrease in fasting plasma glucose level in mild alloxan-induced diabetic rats but not in the rats suffering from ketosis. "
2.	Insulin Resistance 04/01/1986 - "These results suggest that hypoglycemic activity of MTP-1403 may be mechanically different from sulfonylureas and biguanides and beneficial to type II diabetics with hyperinsulinemia and insulin resistance."
3.	Hyperinsulinism (Hyperinsulinemia) 04/01/1986 - "These results suggest that hypoglycemic activity of MTP-1403 may be mechanically different from sulfonylureas and biguanides and beneficial to type II diabetics with hyperinsulinemia and insulin resistance."

1.	Hypoglycemic Agents (Hypoglycemics)
2.	Glucose (Dextrose)
3.	Biguanides
4.	Alloxan